A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in 'reverse signalling'
about
TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative diseaseProfile of certolizumab and its potential in the treatment of psoriatic arthritisAMIGO, a transmembrane protein implicated in axon tract development, defines a novel protein family with leucine-rich repeatsA proteomic screen reveals novel Fas ligand interacting proteins within nervous system Schwann cellsHistorical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journeyThe Structure of the Trimer of Human 4-1BB Ligand Is Unique among Members of the Tumor Necrosis Factor SuperfamilyMultiple interactions of the cytosolic polyproline region of the CD95 ligand: hints for the reverse signal transduction capacity of a death factorIdentification of interaction partners of the cytosolic polyproline region of CD95 ligand (CD178)Tumor necrosis factor alpha and adalimumab differentially regulate CD36 expression in human monocytesTransmembrane chemokines act as receptors in a novel mechanism termed inverse signalingConstitutive smooth muscle tumour necrosis factor regulates microvascular myogenic responsiveness and systemic blood pressureBinding of the intracellular Fas ligand (FasL) domain to the adaptor protein PSTPIP results in a cytoplasmic localization of FasL.PEGylated recombinant human soluble tumour necrosis factor receptor type I (r-Hu-sTNF-RI): novel high affinity TNF receptor designed for chronic inflammatory diseases.Differential effects of total and partial neutralization of tumor necrosis factor on cell-mediated immunity to Mycobacterium bovis BCG infection.TNF alpha and the TNF receptor superfamily: structure-function relationship(s).Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents.Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-kappaB.4-1BB ligand activates bystander dendritic cells to enhance immunization in transDifferential requirements for soluble and transmembrane tumor necrosis factor in the immunological control of primary and secondary Listeria monocytogenes infectionCD95 ligand--death factor and costimulatory molecule?Fas ligand enhances malignant behavior of tumor cells through interaction with Met, hepatocyte growth factor receptor, in lipid rafts.Considering Fas ligand as a target for therapy.Mutation in fas ligand impairs maturation of thymocytes bearing moderate affinity T cell receptorsApoptosis as a therapeutic tool in IBD?Stimulation of bone formation in cortical bone of mice treated with a receptor activator of nuclear factor-κB ligand (RANKL)-binding peptide that possesses osteoclastogenesis inhibitory activity.The dual functions of fas ligand in the regulation of peripheral CD8+ and CD4+ T cells.Phosphorylation events and the modulation of aquaporin 2 cell surface expressionThe TNF family member 4-1BBL sustains inflammation by interacting with TLR signaling components during late-phase activation.Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system.Importance of reverse signaling of the TNF superfamily in immune regulation.Regulation of myelopoiesis by CD137L signaling.CD137 ligand-mediated reverse signals increase cell viability and cytokine expression in murine myeloid cells: involvement of mTOR/p70S6 kinase and Akt.Posttranslational regulation of Fas ligand function.Reverse signalling of membrane-integrated tumour necrosis factor differentially regulates alloresponses of CD4+ and CD8+ T cells against human microvascular endothelial cells.Signalling via CD70, a member of the TNF family, regulates T cell functions.Erk-dependent cytosolic phospholipase A2 activity is induced by CD95 ligand cross-linking in the mouse derived Sertoli cell line TM4 and is required to trigger apoptosis in CD95 bearing cells.TNFα reverse signaling promotes sympathetic axon growth and target innervation.In vitro response pattern of monocytes after tmTNF reverse signaling predicts response to anti-TNF therapy in rheumatoid arthritis.Osteoclast regulation of osteoblasts via RANK‑RANKL reverse signal transduction in vitro.Effects of infliximab on apoptosis and reverse signaling of monocytes from healthy individuals and patients with Crohn's disease.
P2860
Q21093232-DAD6ADBA-6729-4180-9FF5-22B1B960BFE6Q22305856-6D731725-A14A-4D2E-B182-0619E582F7C0Q24297495-5FF46021-1650-485E-8B74-DD6C51F3DFF4Q24338698-48CF06A6-2636-4531-9256-8315457F0D88Q26991848-A3C72773-6928-4F34-AE35-4EA8CD589081Q27658762-3A5D7610-BC8B-4BCC-BBCD-2F325B0F94BEQ28210406-7F609451-E84F-41FA-BDFE-8C9D7E717F51Q28218575-19B0879C-C859-4291-BDE7-EA0B987E9957Q28219857-0FB5D850-904E-431E-B529-F2EA41EB5F68Q28601403-E753E8B4-8DB2-4086-80D2-E1DF4CAA3B13Q30358256-6EA8B5CD-7386-4B7A-A565-FCAF6BAB1260Q33289418-13956C05-5B0D-424D-BA5A-4856B7109BE8Q33782360-0373282E-8077-419C-A48E-A06BC4DEA877Q33787988-574E72FF-42A2-467C-9496-B3C17946957FQ33909217-68239FF1-07BA-4C81-9C02-E71816C42D4DQ33915940-023CB60F-AE05-4B58-9236-2F60435F6673Q34071248-8415D61E-D16F-4FB4-8545-A82A3E18389AQ34628912-8AA19F8D-D008-4CD3-85DE-FB79C663B98AQ34681089-B3DD476C-41CA-411E-8C85-42D19D64399FQ35190128-B24C5F35-5936-49E9-BD6E-E0C151C2AD72Q36016981-A0AC7AB7-0999-4166-AD65-089F29C66676Q36066300-34CEEAA1-E22A-4FF4-8A10-22CD9338D602Q36371320-48A43CBD-92B7-427E-91DA-70A420FE596CQ36631420-5EF435B0-19C4-4E0F-BAE8-D9804D285418Q36636031-76EA2F66-1524-4C9A-AC1E-00644E525965Q37114374-4D600A98-EC48-400D-A729-5AF23701E973Q37174117-458463D8-A948-4549-BE51-6E1114BD8FF5Q37731922-0E6E0EE8-9186-4904-9009-F144C9E07FBEQ37897498-B23E1036-CA37-4BA2-86F8-3C6A3DBBBC29Q38096027-B8132BF6-BE2C-4998-B9D7-CBAB9405F84CQ38221212-181FB9A6-6B35-4772-958B-BEF37B74E38EQ39813213-9F8EC811-76D9-495C-AAF7-D780B3123002Q40015586-DB2E72F2-5463-49E2-9B5E-CD41D1A7C988Q40398654-992475CB-47AD-4729-A130-21F274F04B86Q40540340-A6CDD4AA-15BB-4956-A563-B880DB59D5FAQ40816076-AEA3882D-79D5-422B-9932-D69C7B6C7041Q42050491-C7FA432A-5BF6-4F89-8A37-FB054EF88D1BQ42423697-372D5C1A-2E2A-4462-B227-3F1E3537960DQ42679472-1280978F-FEF3-453B-A91B-26837B798F0CQ45207573-9F97916E-DF90-456A-874C-DE2B697323DE
P2860
A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in 'reverse signalling'
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
A casein kinase I motif presen ...... icated in 'reverse signalling'
@ast
A casein kinase I motif presen ...... icated in 'reverse signalling'
@en
type
label
A casein kinase I motif presen ...... icated in 'reverse signalling'
@ast
A casein kinase I motif presen ...... icated in 'reverse signalling'
@en
prefLabel
A casein kinase I motif presen ...... icated in 'reverse signalling'
@ast
A casein kinase I motif presen ...... icated in 'reverse signalling'
@en
P2093
P2860
P356
P1433
P1476
A casein kinase I motif presen ...... icated in 'reverse signalling'
@en
P2093
Bloomfield G
Chaudhri G
Roufogalis BD
Wanigasekara Y
P2860
P304
P356
10.1093/EMBOJ/18.8.2119
P407
P577
1999-04-01T00:00:00Z